PMID: 2495839Mar 20, 1989Paper

Aberrant phosphorylation of neurofilaments accompanies transmitter-related changes in rat septal neurons following transection of the fimbria-fornix

Brain Research
V E KoliatsosD L Price

Abstract

Lesions of the fimbria-fornix (FF) have been reported to cause retrograde changes in neurons of the medial septal nucleus (MSN). To analyze the nature and time course of these events, we investigated changes in cytoskeletal elements (phosphorylated and non-phosphorylated neurofilament (NF) proteins) and transmitter-related enzymes (choline acetyltransferase (ChAT) in MSN neurons following FF transection. During the first week postlesion, ChAT immunoreactivity and size of many perikarya were reduced. Irregular, swollen cholinergic fibers appeared first at postlesion day 2 in caudal septum and soon spread rostrally, reaching rostral septum by day 7. A few perikarya developed abnormal accumulations of phosphorylated NFs. At postlesion days 7-10, many neurons did not stain for ChAT. Phosphorylated NFs were present in many perikarya. At this time, cell loss was apparent in Nissl-stained material. Cholinergic cell loss continued through postlesion weeks 6-8 but at a much slower rate than during the first week. Phosphorylated NF accumulations in MSN perikarya persisted until postlesion week 6, disappearing thereafter. Double-immunostaining procedures showed that MSN neurons expressed both ChAT and phosphorylated NF immunoreactivity at...Continue Reading

References

Aug 1, 1978·The Journal of Cell Biology·H C PantR J Lasek
Mar 1, 1975·Acta Oto-laryngologica·H Spoendlin
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·K S KosikD J Selkoe
Nov 1, 1986·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·A I LeveyB H Wainer
Jul 1, 1988·Journal of Neuropathology and Experimental Neurology·L C CorkD L Price
May 6, 1987·Neuroscience Letters·G M PetersonF H Gage
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·I Grundke-IqbalL I Binder
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·N H SternbergerJ Ulrich
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P N HoffmanD L Price
Jan 1, 1986·Journal of Neuropathology and Experimental Neurology·L C CorkD L Price
May 1, 1987·Journal of Neuropathology and Experimental Neurology·J RosenfeldD L Price
Oct 15, 1987·The Journal of Comparative Neurology·D M ArmstrongF H Gage
Jul 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·R C PearsonT P Powell
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·G PerryP Gambetti
Jan 1, 1984·Experimental Brain Research·T A Milner, D G Amaral
Dec 21, 1984·Science·C A KittW C Mobley
Mar 1, 1984·Brain : a Journal of Neurology·M M Mesulam, E J Mufson
Oct 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·L A Sternberger, N H Sternberger
Feb 21, 1983·Brain Research·R C PearsonT P Powell
Feb 1, 1954·Journal of Neurology, Neurosurgery, and Psychiatry·H M DAITZ, T P POWELL
Oct 1, 1955·The Journal of Comparative Neurology·T MCLARDY
Jan 1, 1965·Progress in Brain Research·W A BERESFORD
Aug 15, 1979·The Journal of Comparative Neurology·L W Swanson, W M Cowan
Feb 1, 1946·The Anatomical Record·M ABERCROMBIE

❮ Previous
Next ❯

Citations

Mar 31, 1999·Cell Motility and the Cytoskeleton·C Jung, T B Shea
Jan 1, 1993·Molecular Neurobiology·L C Doering
Jun 19, 2007·Journal of Inherited Metabolic Disease·R Pessoa-Pureur, M Wajner
May 11, 1992·Neuroscience Letters·P Klosen, P van den Bosch de Aguilar
Mar 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·R M DijkhuizenK Nicolay
Jan 19, 2000·Progress in Neurobiology·J C VickersG McCormack
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·G F HallK S Kosik
Nov 1, 1992·Journal of Neurobiology·D L PriceL C Cork
Jan 1, 1993·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·P Klosen, P van den Bosch de Aguilar
Sep 4, 1995·The Journal of Comparative Neurology·B J WilcoxV E Koliatsos
Apr 1, 1994·The Journal of Comparative Neurology·V E KoliatsosD L Price
Feb 26, 2016·Brain : a Journal of Neurology·Lukas HaiderHans Lassmann
Sep 3, 1990·Brain Research·P KlosenP van den Bosch de Aguilar
Feb 1, 1989·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·D L PriceA Unterbeck
Oct 22, 2019·Current Opinion in Neurology·Vassilis E Koliatsos, Athanasios S Alexandris
Apr 1, 2009·Journal of Neurotrauma·Clara PenasXavier Navarro
Jan 1, 1990·Toxicologic Pathology·D L PriceP N Hoffman
Jan 1, 1991·Annals of the New York Academy of Sciences·V E KoliatsosD L Price
Jun 10, 1996·The Journal of Comparative Neurology·R E ClatterbuckV E Koliatsos
Apr 14, 2011·Journal of Neuropathology and Experimental Neurology·Vassilis E KoliatsosDeidre Lee
Apr 15, 1991·The Journal of Comparative Neurology·A M Berglund, D K Ryugo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.